For example, in glioblastoma (GBM), SUMO machinery components are upregulated, such as SUMO activating enzyme (SAE1), SUMO conjugating enzyme (Ubc9) and SUMO specific protease (SENP1), promoting tumor progression (14). Here, UBE2I is linked to neoplasm.